Alpha Tau Medical: 2026 Is The Breakthrough Year [Seeking Alpha]
Alpha Tau Medical Ltd. - Ordinary Shares (DRTS)
Company Research
Source: Seeking Alpha
2026 is pivotal for DRTS, with multiple clinical trial readouts expected in cSCC, pancreatic, GBM, and prostate cancers, potentially transforming its market standing. Despite a $42.3M operating loss in 2025 and no revenue, DRTS has about five to six quarters of cash, but dilution risk remains high. I recommend a small buy position in DRTS, as its tumor-agnostic, intratumoral approach and the ongoing M&A activity in the radiopharmaceutical space could make it a compelling takeover target. wildpixel/iStock via Getty Images 2026 may finally be the year Alpha Tau Medical ( DRTS ), an under-the-radar Israeli micro-cap, finally shakes off its obscurity. The firm is quietly developing a significant breakthrough in oncology, pioneering the first way of delivering alpha particle
Show less
Read more
Impact Snapshot
Event Time:
DRTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRTS alerts
High impacting Alpha Tau Medical Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
DRTS
News
- Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased [Yahoo! Finance]Yahoo! Finance
- Alpha Tau to Present at Sidoti March Virtual Small Cap Conference [Yahoo! Finance]Yahoo! Finance
- Alpha Tau to Present at Sidoti March Virtual Small Cap ConferenceGlobeNewswire
- Alpha Tau Medical (DRTS) had its price target raised by Citigroup Inc. from $7.00 to $9.00. They now have a "buy" rating on the stock.MarketBeat
- Alpha Tau Medical (DRTS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.MarketBeat
DRTS
Earnings
- 3/9/26 - Miss
DRTS
Sec Filings
- 3/18/26 - Form 3
- 3/18/26 - Form 3
- 3/18/26 - Form 3
- DRTS's page on the SEC website